Hepatic artery thrombosis (HAT) is the most common vascular complication after liver transplantation, occurring in 2–5% of liver transplant recipients. As such, HAT is a major cause of morbidity ...

Dr. Katherine Poruk, a surgical oncologist at Mayo Clinic, says a specialized therapy known as hepatic artery infusion pump ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral RDN system.

Intera’s main asset is its hepatic artery infusion (HAI) therapy device, the Intera 3000 Hepatic Artery Infusion Pump. The continuous pump is approved by the US Food and Drug Administration (FDA ...